In chronic lymphocytic leukaemia (CLL), a distinct expression of ROR1 on tumour cells has been identified, and ROR1 is currently one out of six markers recommended internationally for refining the diagnosis of CLL [40]. Here, ROR1 is linked to neoplasm.